Skip to main content
. 2018 Jul 26;4:19. doi: 10.1038/s41523-018-0070-x

Fig. 2.

Fig. 2

Mutation prevalence in our cohort (PABC: Premenopausal Asian Breast Cancers) and comparison with premenopausal, non-Asian breast cancer patients in The Cancer Genome Atlas. Starred genes indicate significant difference from TCGA data (FDR q < 0.05). a Comparison of 21 HER2-positive samples against 58 non-Asian TCGA samples. b Comparison of 27 hormone receptor-positive samples against 81 non-Asian TCGA samples. c Comparison of 15 triple-negative breast cancers against 28 non-Asian TCGA samples